ClinicalTrials.gg
Drug

Lovastatin clinical trials

Also written Mevacor, Altoprev and Mevinolin.

studies test it
47
open now
2
in phase 3
7
first study started
1990

How each study uses Lovastatin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lovastatin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Aug 1987 · MEVACOR · NDA 019643 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lovastatin
34
Lovastatin 60 MG
2
Group A
2
Lovastatin Sodium
2
Lovastatin 40 mg Tablets
2

Brand

Mevacor
19
Altoprev
6

Other names

Mevinolin
3
Monacolin K
2

In one entry with another drug

Given together, or one or the other

Niacin Extended Release and Lovastatin Tablets
2

Studies by the year they started

44 studies that test it; most in 2009 (5)

Studies that test Lovastatin, by start year
YearStudies
19901
19961
20011
20034
20043
20052
20073
20082
20095
20101
20111
20122
20153
20164
20171
20183
20192
20202
20211
20241
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
28
Phase 3
7
Phase 4
3
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 40

Columbia University (2) · University of Coimbra (2) · Sanofi (2) · Islamic Azad University, Sanandaj (2) · Université de Sherbrooke (2) · Virginia Commonwealth University (2) · National Taiwan University Hospital (2) · Mutual Pharmaceutical Company, Inc. (2)

Often tested with

Tested in the same studies.

Niacin (6) · Alirocumab (2) · Rosuvastatin (2) · Atorvastatin (2) · Simvastatin (2) · Pravastatin (2) · Fluvastatin (2) · Ezetimibe (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Lovastatin.

Studies

Open first, then newest update. How each study uses Lovastatin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 47

See all 47 studies that test Lovastatin →

Given beside what is tested · 1 — Lovastatin is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Lovastatin

Codes

What other systems call Lovastatin · ClinicalTrials.gg INT007749

  • MeSH (NLM) D008148LovastatinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 9LHU78OQFDLOVASTATINConfirmed FDA, NLM, Wikidata
  • RxNorm 6472Confirmed FDA, Wikidata
  • Wikidata Q417740lovastatinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C620LovastatinOne source FDA
  • DrugBank DB00227One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.